{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:06:33Z","timestamp":1790514393259,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Legacy Heritage Bio-Medical Program (ISF) of the Israel Science Foundation","award":["1070\/15 TO DM"],"award-info":[{"award-number":["1070\/15 TO DM"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.molimm.2017.05.024","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T00:45:15Z","timestamp":1497401115000},"page":"69-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Demyelination, strokes, and eculizumab: Lessons from the congenital CD59 gene mutations"],"prefix":"10.1016","volume":"89","author":[{"given":"Adi","family":"Tabib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netanel","family":"Karbian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Mevorach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2017.05.024_bib0005","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barre syndrome","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molimm.2017.05.024_bib0010","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ejpn.2015.07.001","article-title":"Devastating recurrent brain ischemic infarctions and retinal disease in pediatric patients with CD59 deficiency","volume":"19","author":"Ben-Zeev","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.molimm.2017.05.024_bib0015","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","article-title":"Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria","volume":"111","author":"Brodsky","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2017.05.024_bib0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI112773","article-title":"Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement:Relationship to defects in the regulation of complement and to platelet survival in vivo","volume":"79","author":"Devine","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2017.05.024_bib0025","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1523\/JNEUROSCI.4279-04.2005","article-title":"Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy","volume":"25","author":"Goodfellow","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molimm.2017.05.024_bib0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI37338","article-title":"The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice","volume":"119","author":"Greenshields","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2017.05.024_bib0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09537105310001657110","article-title":"The platelet function defect of paroxysmal nocturnal haemoglobinuria","volume":"15","author":"Grunewald","year":"2004","journal-title":"Platelets"},{"key":"10.1016\/j.molimm.2017.05.024_bib0040","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.1147103","article-title":"Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense","volume":"317","author":"Hadders","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.molimm.2017.05.024_bib0045","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molimm.2017.05.024_bib0050","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1212\/WNL.0000000000001391","article-title":"Early-onset chronic axonal neuropathy, strokes, and hemolysis: inherited CD59 deficiency","volume":"84","author":"Haliloglu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.molimm.2017.05.024_bib0055","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awm316","article-title":"Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model","volume":"131","author":"Halstead","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.molimm.2017.05.024_bib0060","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3324\/haematol.2009.016121","article-title":"Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab","volume":"95","author":"Helley","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.molimm.2017.05.024_bib0065","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria","volume":"121","author":"Hill","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2017.05.024_bib0070","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2017.05.024_bib0075","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","article-title":"Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria","volume":"110","author":"Hillmen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2017.05.024_bib0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJMc1308104","article-title":"Targeted therapy with eculizumab for inherited CD59 deficiency","volume":"370","author":"Hochsmann","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2017.05.024_bib0085","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1468-1331.2006.01278.x","volume":"13","author":"Hughes","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.molimm.2017.05.024_bib0090","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1097\/PRS.0b013e3181a65a27","article-title":"A novel model to measure the regenerative potential of the peripheral nervous system after experimental immunological demyelination","volume":"123","author":"Kosins","year":"2009","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.molimm.2017.05.024_bib0095","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s002770100350","article-title":"Abnormal platelet adhesion on abdominal vessels in asymptomatic patients with paroxysmal nocturnal hemoglobinuria","volume":"80","author":"Louwes","year":"2001","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.molimm.2017.05.024_bib0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0049-3848(96)00153-3","article-title":"Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria","volume":"83","author":"Maciejewski","year":"1996","journal-title":"Thromb. Res."},{"key":"10.1016\/j.molimm.2017.05.024_bib0105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4049\/jimmunol.168.1.458","article-title":"The membrane attack complex of complement causes severe demyelination associated with acute axonal injury","volume":"168","author":"Mead","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.05.024_bib0110","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/ana.24770","article-title":"Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation","volume":"80","author":"Mevorach","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molimm.2017.05.024_bib0115","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/eji.1830221029","article-title":"Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene","volume":"22","author":"Motoyama","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2017.05.024_bib0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood-2012-07-441857","article-title":"CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy","volume":"121","author":"Nevo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2017.05.024_bib0125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/01.CIR.93.2.327","article-title":"Enhancement of platelet deposition by cross-linked hemoglobin in a rat carotid endarterectomy model","volume":"93","author":"Olsen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.molimm.2017.05.024_bib0130","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/cdd.2013.113","article-title":"Mechanisms of haptoglobin protection against hemoglobin peroxidation triggered endothelial damage","volume":"20","author":"Schaer","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molimm.2017.05.024_bib0135","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-2141.2004.04974.x","article-title":"Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria","volume":"125","author":"Simak","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molimm.2017.05.024_bib0140","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9343(88)80092-5","article-title":"Thrombophlebitis and disturbed hemostasis following administration of intravenous hematin in normal volunteers","volume":"85","author":"Simionatto","year":"1988","journal-title":"Am. J. Med."},{"key":"10.1016\/j.molimm.2017.05.024_bib0145","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0167-5699(91)90012-I","article-title":"The response of human platelets to activated components of the complement system","volume":"12","author":"Sims","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1016\/j.molimm.2017.05.024_bib0150","doi-asserted-by":"crossref","first-page":"19228","DOI":"10.1016\/S0021-9258(19)47291-8","article-title":"Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex","volume":"264","author":"Sims","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2017.05.024_bib0155","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2004-06-2096","article-title":"Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin","volume":"105","author":"Studt","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2017.05.024_bib0160","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0092-8674(93)90250-T","article-title":"Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria","volume":"73","author":"Takeda","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2017.05.024_bib0165","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood.V82.4.1192.1192","article-title":"Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria","volume":"82","author":"Wiedmer","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2017.05.024_bib0170","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJM199010253231707","article-title":"Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria","volume":"323","author":"Yamashina","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2017.05.024_bib0175","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barre syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2017.05.024_bib0180","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1538-7836.2007.02379.x","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome An overview","volume":"5","author":"Ziakas","year":"2007","journal-title":"J. Thromb Haemost."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158901730158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158901730158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T07:32:58Z","timestamp":1621063978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016158901730158X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":36,"alternative-id":["S016158901730158X"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2017.05.024","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Demyelination, strokes, and eculizumab: Lessons from the congenital CD59 gene mutations","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2017.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}